| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 625 | 312 | 313 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| SOLVENTUM CORP | 2023-10 | PURCHASE | 2024-04 | 40 | 34 | 6 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| EQUITIES | 185,208 | 185,208 |
| MUTUAL FUNDS | 523,109 | 523,109 |
| EXCHANGE TRADED FUNDS | 14,087 | 14,087 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| MISCELLANEOUS | 600 | 300 | 300 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| UNREALIZED GAINS ON INVESTMENTS | 216,105 | 249,994 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAXES | 341 |